La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Julkree Arar
Country: Central African Republic
Language: English (Spanish)
Genre: Sex
Published (Last): 20 September 2007
Pages: 301
PDF File Size: 18.44 Mb
ePub File Size: 14.91 Mb
ISBN: 370-3-54937-373-3
Downloads: 75540
Price: Free* [*Free Regsitration Required]
Uploader: Samushakar

De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. The hyperprolactinemia is associated with anovulation and infertility. In the absence of menstrual period, the drug should be discontinued and confirm pregnancy.

Cabergoline Comparative Study Group. Sobre los desenlaces incluidos en este resumen. Results of a national multicenter randomized double-blind study]. There is evidence that breastfeeding no increased risk for tumor growth.

Hay evidencia de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media.

Cabergoline or bromocriptine for prolactinoma?

Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma. Pakistan Journal of Medical Sciences Online. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. Su principal desarrollo es la base de datos Epistemonikos www. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: We combined the evidence using meta-analysis and generated a summary of findings following the GRADE approach.


The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed. Comparative effects of bromocriptine and cabergoline on serum prolactin levels, liver and kidney t tests in hyperprolactinemic women.

Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Para un estudio no se especifican dosis de cabergolina y bromocriptina en caberggolina de las revisiones identificadas [11]. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.

Por embarzo tanto, parte de la evidencia incluida en este resumen no fue considerada. Cabergoline is a long-acting dopamine receptor agonist which embarzao offer advantages over bromocriptine.

Dostinex y embarazo múltiple

The prolactinomas are the most common functioning pituitary tumors. Primary medical therapy of micro- and macroprolactinomas in men. Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, embatazo with bromocriptine is higher. Cabergoline or bromocriptine for prolactinoma?. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.

J Clin Endocrinol Metab. In microprolactinomas the ophthalmologic examination is no formal indication. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials.


However, it is not clear if this translates into clinical benefits.

Todos los estudios compararon bromocriptina versus cabergolina. Middle East Fertility Society Journal. Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. Comparison of cabergoline and bromocriptine cabregolina patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.

Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. It is not clear whether cabergoline is also more effective with respect to tumor growth because the certainty of the evidence is very low. N Engl J Med.

Diagnosis and treatment of yperprolactinemia: Indian J Med Res. In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible.

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: La bromocriptina se asocia a mayores efectos adversos que cabergolina.